IMPAX Laboratories Aktie
WKN: 938461 / ISIN: US45256B1017
|
08.01.2015 22:37:00
|
Impax Laboratories, Inc. -- Moody's: FDA Approval of Rytary Credit Positive for Impax Labs
New York, January 08, 2015 -- Moody's Investors Service commented that the Food and Drug Administration's (FDA) approval of Rytary is a credit positive for Impax Laboratories, Inc. (B1 Stable). Rytary was Impax's most important pipeline drug and over time we expect it to add meaningfully to Impax's revenue and cash flow. There is no change to Impax's rating or outlook at this time. Please go to www.moodys.com for our full Issuer Comment.
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.